The lawsuit comes after Replimune investors witnessed a 77% collapse in the price of their shares on July 22 when the company announced that the Food and Drug Administration (FDA) had rejected its ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Replimune Group, Inc. (NASDAQ: REPL) resulting from ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. A visit to the chiropractor can provide many health benefits.

Replimune stock fell after the FDA rejected its RP1 application, citing flaws in the trial design and lack of substantial evidence for approval.

Replimune (REPL) stock plummeted on Tuesday after the biotechnology company received a Complete Response Letter (CRL) from ...

The market reacted swiftly, sending the price of Replimune shares crashing 77% lower on unusually high volume on July 22, 2025. “We're investigating whether Replimune may have misled investors about ...

Nintendo Switch 2 stock is springing back onto the shelves this week, with US retailers back in action and UK stock at an all-time high.

Here's all the latest information on how to buy the Switch 2 and where you can get one.